Cargando…
Methylenetetrahydrofolate reductase gene C677T polymorphism and breast cancer risk: Evidence for genetic susceptibility
There are several evidences supporting the role of 5–10 methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms in breast cancer (BC). Case control association studies on breast cancer have been repeatedly performed over the last two decades, but results are inconsistent. We performed a meta-...
Autores principales: | Kumar, Pradeep, Yadav, Upendra, Rai, Vandana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634353/ https://www.ncbi.nlm.nih.gov/pubmed/26629412 http://dx.doi.org/10.1016/j.mgene.2015.08.008 |
Ejemplares similares
-
Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh
por: Rai, Vandana, et al.
Publicado: (2012) -
Maternal Methylenetetrahydrofolate Reductase C677T Polymorphism and Down Syndrome Risk: A Meta-Analysis from 34 Studies
por: Rai, Vandana, et al.
Publicado: (2014) -
Methylenetetrahydrofolate reductase (MTHFR) gene C677T (rs1801133) polymorphism and risk of alcohol dependence: a meta-analysis
por: Rai, Vandana, et al.
Publicado: (2021) -
Methylenetetrahydrofolate reductase polymorphism is not risk factor for Down syndrome in North India
por: Rai, Vandana, et al.
Publicado: (2014) -
Methylenetetrahydrofolate reductase A1298C genetic variant & risk of schizophrenia: A meta-analysis
por: Rai, Vandana, et al.
Publicado: (2017)